82,61 €
91,79 €
-10% with code: EXTRA
Joint Hypermobility Syndrome (JHS)
Joint Hypermobility Syndrome (JHS)
82,61
91,79 €
  • We will send in 10–14 business days.
This book deals with a health issue, the main topic is joint hyperlaxity syndrome or also known as joint hypermobility syndrome (JHS). It is considered a rare disease since its incidence in people is a minority, its diagnosis is made by discarding since there is no genetic test to rule it out. The great majority of rheumatic diseases are difficult to diagnose since they share part of the symptomatology. The aim of the present study is to provide information on pharmacological and non-pharmacolo…
  • SAVE -10% with code: EXTRA

Joint Hypermobility Syndrome (JHS) (e-book) (used book) | bookbook.eu

Reviews

Description

This book deals with a health issue, the main topic is joint hyperlaxity syndrome or also known as joint hypermobility syndrome (JHS). It is considered a rare disease since its incidence in people is a minority, its diagnosis is made by discarding since there is no genetic test to rule it out. The great majority of rheumatic diseases are difficult to diagnose since they share part of the symptomatology. The aim of the present study is to provide information on pharmacological and non-pharmacological treatments in patients diagnosed with SHA, published in the last 5 years.

EXTRA 10 % discount with code: EXTRA

82,61
91,79 €
We will send in 10–14 business days.

The promotion ends in 15d.07:58:36

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 0,92 Book Euros!?

This book deals with a health issue, the main topic is joint hyperlaxity syndrome or also known as joint hypermobility syndrome (JHS). It is considered a rare disease since its incidence in people is a minority, its diagnosis is made by discarding since there is no genetic test to rule it out. The great majority of rheumatic diseases are difficult to diagnose since they share part of the symptomatology. The aim of the present study is to provide information on pharmacological and non-pharmacological treatments in patients diagnosed with SHA, published in the last 5 years.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)